Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
07/14/2005 | WO2005063748A1 β-CARBOLINE DERIVED GUANIDINE ALKALOID, TIRUCHENDURAMINE |
07/14/2005 | WO2005063747A1 PYRROLO[2,3-b] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THEM |
07/14/2005 | WO2005063746A1 PYRROLO[2,3-b]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM |
07/14/2005 | WO2005063745A2 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
07/14/2005 | WO2005063744A2 IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT |
07/14/2005 | WO2005063739A1 Novel quinoline derivatives |
07/14/2005 | WO2005063704A1 Azetidine ring compounds and drugs comprising the same |
07/14/2005 | WO2005062991A2 Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers |
07/14/2005 | WO2005062795A2 Compounds and methods for development of ret modulators |
07/14/2005 | WO2005056550A3 Heterocyclic anti-migraine agents |
07/14/2005 | WO2005046612A3 Hydroxy piperidine derivatives to treat gaucher disease |
07/14/2005 | WO2005040073A3 Solid phase synthesis of 3-aryl-2- indolylcarboxylic acids |
07/14/2005 | WO2004113277A8 Methods and compositions for treating amyloid-related diseases |
07/14/2005 | US20050154208 Efficient electron transport and hole blocking; organic electroluminescent device |
07/14/2005 | US20050154202 Substituted aryl amides |
07/14/2005 | US20050154039 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
07/14/2005 | US20050154014 Anticarcinogenic agents; antitumor agents treating cancer of breast, head, neck, gastrointestinal system or stomach, ovaries, bronchi, lungs or pancreas; leukemia |
07/14/2005 | US20050154012 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
07/14/2005 | US20050154008 Aryl fused substituted 4-oxy-pyridines |
07/14/2005 | US20050154007 Substituted imidazo[1,2-a]pyridines such as 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-6-methoxyimidazo[1,2-a]pyridine, used as antisectory agents for prophylaxis of gastrointestinal disorders |
07/14/2005 | US20050154005 Administering to a subject in need of such treatment an effective amount of 1,1'-[1,4-(phenylenebis(methylene))]bis-1,4,8,11-tetraazacyclotetradecane or a pharmaceutical composition thereof, wherein the inhibition of CXCR4 receptor binding effects treatment or amelioration of said condition |
07/14/2005 | US20050154001 cCs-rac-4-phenyl-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one; treating diseases related to activation of NMDA receptors via Glyt-1 inhibition |
07/14/2005 | US20050154000 Diaza-spiropiperidine derivatives |
07/14/2005 | US20050153998 Tetrahydroisoquinoline or isochroman compounds |
07/14/2005 | US20050153986 Psychiatric and mood disorders, Bipolar Disorder, Circadian rhythm disorders, sleep disorders, pain, Parkinson's disease, cognitive dysfunction, epilepsy, obesity, drug addiction, drug abuse, drug withdrawal; side effects reduction; 1-Methyl-3-[3-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]imidazolidin-2-one |
07/14/2005 | US20050153980 Substituted indoles |
07/14/2005 | US20050153979 Novel piperidine-substituted indoles-or heteroderivatives thereof |
07/14/2005 | US20050153978 Medicaments |
07/14/2005 | US20050153966 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
07/14/2005 | US20050153964 Novel compounds |
07/14/2005 | US20050153960 Substituted arylamine derivatives and methods of use |
07/14/2005 | US20050153959 Heterocyclic anti-migraine agents |
07/14/2005 | US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof |
07/14/2005 | US20050151467 Electrochromic salts, solutions, and devices |
07/14/2005 | CA2552207A1 Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same |
07/14/2005 | CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds |
07/14/2005 | CA2550689A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
07/14/2005 | CA2550686A1 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
07/14/2005 | CA2550361A1 Compounds and methods for development of ret modulators |
07/14/2005 | CA2549898A1 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
07/14/2005 | CA2549606A1 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
07/14/2005 | CA2546147A1 Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
07/13/2005 | EP1553099A1 A riboflavin derivative and its manufacture and uses |
07/13/2005 | EP1553098A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
07/13/2005 | EP1553097A1 Quinazoline derivatives as angiogenesis inhibitors and intermediates therefore |
07/13/2005 | EP1552842A1 Bicyclic pyrimidine derivatives |
07/13/2005 | EP1552836A1 Anti-neurodegenerative agents |
07/13/2005 | EP1551902A2 Anisotropic films based on 1,8-naphthoylene-1 ,2 -benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making |
07/13/2005 | EP1551849A1 Tricyclic tetrahydroquinoline antibacterial agents |
07/13/2005 | EP1551844A2 Antitumoral analogs of lamellarins |
07/13/2005 | EP1551840A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
07/13/2005 | EP1551836A1 Azabicyclic amine derivatives as nk-1 receptor antagonists |
07/13/2005 | EP1551835A1 Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
07/13/2005 | EP1551834A1 Substituted quinazolinone compounds |
07/13/2005 | EP1551831A1 Method for preparing risperidone |
07/13/2005 | EP1551829A2 Novel compounds with antibacterial activity |
07/13/2005 | EP1551828A1 Pyrazole derivatives |
07/13/2005 | EP1551811A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
07/13/2005 | EP1551809A1 Pyrazole compounds for treatment of neurodegenerative disorders |
07/13/2005 | EP1551804A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
07/13/2005 | EP1551511A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
07/13/2005 | EP1551461A2 Azo compounds for type i phototherapy |
07/13/2005 | EP1551400A2 Preparation of triazospiro compounds |
07/13/2005 | EP1551398A1 Pyrazolopyridines and methods of making and using the same |
07/13/2005 | EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity |
07/13/2005 | EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
07/13/2005 | EP0977755B1 Heterocyclic compounds and their preparation and use |
07/13/2005 | CN1639165A Purine derivatives as kinase inhibitors |
07/13/2005 | CN1639163A Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6, 7, 8, 9-tetrahydro-4h-pyrido-(1, 2-a) pyrimidin-4-one |
07/13/2005 | CN1639162A Pyrido(2, 1-a)isoquinoline derivatives as DPP-IV inhibitors |
07/13/2005 | CN1639161A Alkyne-aryl phosphodiesterase-4 inhibitors |
07/13/2005 | CN1639160A Process for preparing crystalline form I of cabergoline |
07/13/2005 | CN1639152A Pyrrole-2, 5-dione derivatives and their use as GSK-3 inhibitors |
07/13/2005 | CN1639147A Synthesis of 4, 5-dihydro-pyrazolo [3, 4-c] pyrid-2-ones |
07/13/2005 | CN1639135A N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials |
07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
07/13/2005 | CN1638776A Substituted 3-aryl-5-aryl-[1, 2, 4]-oxadiazoles and analogs |
07/13/2005 | CN1638762A Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
07/13/2005 | CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides |
07/13/2005 | CN1636996A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
07/13/2005 | CN1636995A Naphthalenetetracarboxylic acid diimide derivatives and electrophotographic photoconductive material using the derivatives |
07/13/2005 | CN1636992A Process for producing quinazoline ditosylate salt compounds |
07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
07/13/2005 | CN1210277C Heteroaryl diazabicycloalkanes, their prepn. and use |
07/13/2005 | CN1210275C Respiratory syncytial virus replication inhibitors |
07/13/2005 | CN1210267C 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
07/13/2005 | CN1210265C Phthalazine derivatives and remedies for erectile dysfunction |
07/12/2005 | US6916928 Functionalized perylene tetracarboxylic acid diimides |
07/12/2005 | US6916925 Dye labeled imidazoquinoline compounds |
07/12/2005 | US6916827 Central nervous system disorders |
07/12/2005 | US6916826 Substituted imidazo[1,2-a]pyridine derivatives |
07/12/2005 | US6916825 Alkylated imidazopyridine derivatives |
07/12/2005 | US6916819 Benzimidazole and pyridylimidazole derivatives |
07/12/2005 | US6916818 Nitrogen compounds such as 1-(1-Naphthalenesulfonyl)-3-(octa-hydro-4-quinolizinyl)-1H-5-azaindole, used as serotonin receptor antagonists for prophylaxis of psychological disorders |
07/12/2005 | US6916810 αν integrin receptor antagonists |
07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |